Drug and Alcohol Screening Market - Forecasts from 2019 to 2024

September 2019 | 100 pages | ID: DECDFF8D87F4EN
Knowledge Sourcing Intelligence LLP

Abstracts

Drug and alcohol screening test mainly analyze biological samples such as urine, blood, and hair to diagnose the presence of the drug. The rise in alcohol consumption, overuse of prescribed drugs, the rise in usage of narcotics and illicit drugs are driving the global drug and alcohol screening market. The drug and alcohol screening market are projected to grow at a CAGR of 11.75% by the year 2024. The enforcement of strict laws and regulation in various countries and financial support from the government are the key growth factors of drug and alcohol screening market. Rise in alcohol and drug abuse, growing knowledge, and awareness among developing countries, growing aging population and competition among leading manufacturers in drug and alcohol screening market for innovative products are the reason for the increasing demand for drug and alcohol screening. Technological advancement is expected to boost the market over the world for the forecast period. The ban on alcohol and drug consumption in some countries and accuracy issues in testing instruments are hindering the growth of the market in the coming years.

In terms of geography, the global drug and alcohol screening market has been classified into North America, South America, Middle East, and Africa, Europe, and Asia-Pacific. Government policies towards drug usage are helping to grow more in North America. Asia-Pacific region is going to be a new hub for exporting dug screening instruments. Companies like, Alere Inc. has started its operation in India in 2016.

Key players operating in the global drug and alcohol screening market are Abbott, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd and OraSure Technologies, among others.

Segmentation

The drug and alcohol screening market has been analyzed through the following segments:

By Sample Type

Urine

Breath

Oral Fluid

Blood

Others

By End-User

Hospitals and Treatment Facilities

Law and Enforcement

Sporting Events

Others

By Geography

North America

United States

Canada

Mexico

South America

Brazil

Argentina

Others

Europe

United Kingdom

Germany

France

Italy

Others

Middle East and Africa

United Arab Emirates

Israel

Saudi Arabia

Others

Asia Pacific

China

Japan

India

South Korea

Others

Contents

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Secondary Sources

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Forces Analysis
  4.5.1. Bargaining Power of Suppliers
  4.5.2. Bargaining Power of Buyers
  4.5.3. Threat of New Entrants
  4.5.4. Threat of Substitutes
  4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness

5. DRUG AND ALCOHOL SCREENING MARKET BY SAMPLE TYPE

5.1. Urine
5.2. Breath
5.3. Oral Fluid
5.4. Blood
5.5. Others

6. DRUG AND ALCOHOL SCREENING MARKET BY END-USER

6.1. Hospitals and Treatment Facilities
6.2. Law and Enforcement
6.3. Sporting Events
6.4. Others

7. DRUG AND ALCOHOL SCREENING MARKET BY GEOGRAPHY

7.1. North America
  7.1.1. USA
  7.1.2. Canada
  7.1.3. Mexico
7.2. South America
  7.2.1. Brazil
  7.2.2. Argentina
  7.2.3. Others
7.3. Europe
  7.3.1. United Kingdom
  7.3.2. Germany
  7.3.3. France
  7.3.4. Italy
  7.3.5. Others
7.4. Middle East and Africa
  7.4.1. UAE
  7.4.2. Israel
  7.4.3. Saudi Arabia
  7.4.4. Others
7.5. Asia Pacific
  7.5.1. China
  7.5.2. Japan
  7.5.3. India
  7.5.4. South Korea
  7.5.5. Others

8. COMPETITIVE INTELLIGENCE

8.1. Market Positioning Matrix and Ranking
8.2. Recent Investments and Deals
8.3. Strategies of Key Players

9. COMPANY PROFILES

9.1. Abbott
9.2. Premier Biotech, Inc.
9.3. Dr?gerwerk AG & Co.
9.4. OraSure Technologies Inc.
9.5. Alfa Scientific Designs, Inc.
9.6. Lifeloc Technologies Inc.
9.7. Express Diagnostics Int’l
9.8. F. Hoffmann-La Roche Ltd
9.9. Shimadzu Corporation
9.10. Siemens Healthineers